Literature DB >> 23647094

Nicotine levels after IV nicotine and cigarette smoking in men.

Nancy K Mello1, Mackenzie R Peltier, Haley Duncanson.   

Abstract

There has been considerable interest in the pharmacodynamics and pharmacokinetics of nicotine and the influence of different routes of administration. However, these variables are often examined in separate studies, and there is less information about the temporal relation between subjective reports and plasma nicotine levels. This study examined the time course and magnitude of plasma nicotine levels and reports of subjective "high" in nicotine-dependent men after 12 or more hrs of abstinence. The effects of two doses of IV nicotine and two doses of nicotine from cigarette smoking were compared, and samples were collected at 2-min intervals. Plasma nicotine levels after smoking a high-nicotine cigarette were significantly greater than after either dose of IV nicotine (p < .001). However, Visual Analog Scale (VAS) ratings of "high" after both doses of IV nicotine and smoking a high-nicotine cigarette did not differ significantly, and followed a similar time course. After smoking a low-nicotine cigarette, VAS ratings of "high" were significantly lower than after either IV nicotine dose or smoking a high-nicotine cigarette (p < .001). Peak levels of "high" were reported within 2 min after IV nicotine administration and the onset of cigarette smoking. Then "high" ratings abruptly decreased, while plasma nicotine rose to peak levels within 4 to 6 min after IV nicotine and 12 to 14 min during cigarette smoking. Plasma nicotine levels did not appear to determine the magnitude or time course of subjective effects under these conditions. PsycINFO Database Record (c) 2013 APA, all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23647094      PMCID: PMC9086919          DOI: 10.1037/a0031799

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.492


  46 in total

Review 1.  Neural mechanisms underlying nicotine addiction: acute positive reinforcement and withdrawal.

Authors:  S S Watkins; G F Koob; A Markou
Journal:  Nicotine Tob Res       Date:  2000-02       Impact factor: 4.244

Review 2.  Placebo cigarettes in smoking research.

Authors:  M L Robinson; E J Houtsmuller; E T Moolchan; W B Pickworth
Journal:  Exp Clin Psychopharmacol       Date:  2000-08       Impact factor: 3.157

3.  Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine.

Authors:  M R Picciotto; M Zoli; R Rimondini; C Léna; L M Marubio; E M Pich; K Fuxe; J P Changeux
Journal:  Nature       Date:  1998-01-08       Impact factor: 49.962

4.  Arterial and venous cocaine plasma concentrations in humans: relationship to route of administration, cardiovascular effects and subjective effects.

Authors:  S M Evans; E J Cone; J E Henningfield
Journal:  J Pharmacol Exp Ther       Date:  1996-12       Impact factor: 4.030

5.  Effects of infusion rate of intravenously administered morphine on physiological, psychomotor, and self-reported measures in humans.

Authors:  L A Marsch; W K Bickel; G J Badger; J P Rathmell; M D Swedberg; B Jonzon; C Norsten-Höög
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

6.  α4β2 nicotinic acetylcholine receptors on dopaminergic neurons mediate nicotine reward and anxiety relief.

Authors:  Tresa M McGranahan; Natalie E Patzlaff; Sharon R Grady; Stephen F Heinemann; T K Booker
Journal:  J Neurosci       Date:  2011-07-27       Impact factor: 6.167

7.  Arteriovenous differences in plasma concentration of nicotine and catecholamines and related cardiovascular effects after smoking, nicotine nasal spray, and intravenous nicotine.

Authors:  S G Gourlay; N L Benowitz
Journal:  Clin Pharmacol Ther       Date:  1997-10       Impact factor: 6.875

Review 8.  Hormones, nicotine, and cocaine: clinical studies.

Authors:  Nancy K Mello
Journal:  Horm Behav       Date:  2009-10-14       Impact factor: 3.587

9.  Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic-pituitary-adrenal axis hormones and mood in men.

Authors:  Jack H Mendelson; Nathalie Goletiani; Michelle B Sholar; Arthur J Siegel; Nancy K Mello
Journal:  Neuropsychopharmacology       Date:  2007-05-16       Impact factor: 7.853

Review 10.  Nicotine delivery kinetics and abuse liability.

Authors:  J E Henningfield; R M Keenan
Journal:  J Consult Clin Psychol       Date:  1993-10
View more
  8 in total

1.  How Intravenous Nicotine Administration in Smokers Can Inform Tobacco Regulatory Science.

Authors:  Kevin P Jensen; Elise E DeVito; Mehmet Sofuoglu
Journal:  Tob Regul Sci       Date:  2016-10-01

2.  Effects of cigarette smoke on aerobic capacity and serum MDA content and SOD activity of animal.

Authors:  Jian-Ping Hu; Xin-Ping Zhao; Xiao-Zhi Ma; Yi Wang; Li-Jun Zheng
Journal:  Int J Clin Exp Med       Date:  2014-11-15

3.  Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers.

Authors:  Gerald W Valentine; Elise E DeVito; Peter I Jatlow; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  J Psychopharmacol       Date:  2018-05-23       Impact factor: 4.153

4.  Effect of Menthol-preferring Status on Response to Intravenous Nicotine.

Authors:  Elise E DeVito; Gerald W Valentine; Aryeh I Herman; Kevin P Jensen; Mehmet Sofuoglu
Journal:  Tob Regul Sci       Date:  2016-10

5.  Modeling Temperature-Dependent Dermal Absorption and Clearance for Transdermal and Topical Drug Applications.

Authors:  Terri D LaCount; Qian Zhang; Jinsong Hao; Priyanka Ghosh; Sam G Raney; Arjang Talattof; Gerald B Kasting; S Kevin Li
Journal:  AAPS J       Date:  2020-05-10       Impact factor: 4.009

Review 6.  More than Smoke and Patches: The Quest for Pharmacotherapies to Treat Tobacco Use Disorder.

Authors:  M J Moerke; L R McMahon; J L Wilkerson
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

7.  The effects of inhaled flavors on intravenous nicotine.

Authors:  R Ross MacLean; Ralitza Gueorguieva; Elise E DeVito; MacKenzie R Peltier; Suprit Parida; Mehmet Sofuoglu
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-28       Impact factor: 3.157

8.  Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.

Authors:  Micah L Berman; Allison M Glasser
Journal:  Nicotine Tob Res       Date:  2019-12-23       Impact factor: 4.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.